Erman Akkus, Medicine Oncology and Internal Medicine Specialist at Ankara University, shared on X:
“Our new study has been published!
Coskun Yazgan, Emre Yekedüz, Yüksel Ürün.
Prostate Cancer and PARPi: Thromboembolic Risk
Increased risk of thrombosis with PARPi compared to controls: 4.3% vs. 2.2%, OR:1.98, 95% CI: 1.06-3.70, P=0.030
Should be considered when deciding prophylaxis in patients with prostate cancer treated with PARPi.
Thanks a lot to Yüksel Ürün and Emre Yekedüz for their support and mentoring. What a great chance to be in the same department!”
Source: Erman Akkus/X
OncoDaily
